Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0000950170-25-102161

EVP, Chief Development Officer acquired 11,695 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Forbes William P · EVP, Chief Development Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-07-31 Exercise or conversion : show line 1 in the form +11,695 150,635 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-07-31 Exercise or conversion : show line 2 in the form Restricted Stock Units −11,695 163,721 D
Loading xslF345X05/ownership.xml…